FEATURE REHABILITATION
of the affected joint is the only, but not always satisfying, option available.
HOPE FOR OSTEOARTHRITIS SUFFERERS The significance of a non-invasive cure, which effectively eliminates pain, demonstrably regenerates cartilage, and sustainably improves movement is to be prized highly. For a number of years, the German company MedTec Medizintechnik GmbH has developed and scientifically proven this type of therapeutic system for non-invasive regenerative cell stimulation with nuclear magnetic resonance therapy (NMR). This innovative cure known by its brand name MBST®
is based on the
same technology used for MRI. The device for this therapy has produced highly significant results during numerous international clinical trials and application reviews, in-vitro studies and animal models. The clinical effectiveness can be proven, including sustainability of the results. Clinical studies have recently been confirmed by data evaluation of thousands of patients, as well as by international collaborations in basic genetic research.
LATEST RESEARCH CORROBORATES MEDICAL EVIDENCE A research group in Austria, led by Prof. Dr. W. Kullich from the Ludwig Boltzmann Institute of Rehabilitation, Saalfelden, Austria, has scientifically investigated the treatment of over 4,500 patients at varying stages of osteoarthritis with NMR. The results of the multi-center evaluation over a period of ten years clearly demonstrate a significant benefit. This study corroborates the medical evidence of this revolutionary method. Sustainable improvement can be achieved by the use of nuclear magnetic resonance therapy with regards to pain and to functional disability in daily activities. The researchers see the therapy, which is easy to use and risk-free for the patient, as the future of medical science in terms of orthopaedics and rehabilitation as well as other areas. Additional confirmation is provided by current research by Prof. Dr. W. van Laack, Laboratory for Biomechanics at the University of Applied Sciences, Aachen-Jülich, Germany. He was able to prove unequivocally that patients with osteoarthritis of the knee benefit by up
to four years from the therapeutic use of NMR, and were thus able to postpone joint replacement.
CELL RESEARCH CONFIRMS PRACTICAL RESULTS Prof. Dr. W. Kullich, LBI, and Prof. H.G. Kress from the clinical department for specialized anesthesia and pain therapy at the Medical University of Vienna, Austria, investigated the effect of NMR with low field strength on human cells at a cellular and genetic level using the most modern scientific methods available. The gene array data and other genetic analyses confirm relevant changes of specific pathways by NMR treatment. This means that the therapeutic use of NMR can have a clearly detectable effect on the cells. The regulative signal cascade of the family Nuclear Factor of Activated T-cells is uniformly stimulated by NMR. “Our most recent results show, that
there is no production of the multifunctional protein TWEAK in specific cell lines, having been stimulated by NMR“, says Prof. Kullich. This fact is of greatest significance because TWEAK is involved in the regulation of cell death, angiogenesis, proliferation, and inflammatory mechanisms causing bone and cartilage damage. Additional research on special endothelial tissue growth factors (VEGFs) shows the positive effect of MRT on the growth and survival of bone and cartilage cells as well as blood vessels. Further research details will be presented at the MedTec exhibition stand.
NEW HI-TECH DEVELOPMENTS FOR DERMATOLOGY, COSMETICSAND VETERINARY SCIENCE On the basis of international research results, the scope of use for nuclear magnetic resonance therapy was expanded into the fields of dermatology and
Arab Health Show Issue 2012 45
cosmetics as well as veterinary science. For each specific domain, the course of NMR has been adapted to the specific target tissue in line with the respective research results, whilst the relevant applicators and control equipment have been developed for new innovative treatment systems. With regard to its user- and patient- friendliness as well as its ability to reduce pain without side effects, MBST®
is not
only a meaningful alternative and extension to today’s therapeutic treatment options, but it will become the global standard form of treatment for conditions such as osteoarthritis and osteoporosis. This can be of particular hope to such patients, as a great number of MBST®
therapy systems
are already being successfully used in many countries around the world. In terms of the cost-benefit, it is clear that the treatment of diseases like osteoarthritis with long lasting therapy-effects provides an economical alternative that can contribute to significant savings in the public health sector. ■
AH
MORE INFO Further information can be found at www.
mbst-medical.com. MedTec Medizintechnik GmbH is an exhibitor at Arab Health 2012, find them in Sheikh Saeed Hall 3, booth S3C40
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196